Pharmaceutical Committee

The Pharmaceutical Committee represents the innovative American pharmaceutical industry in the Netherlands. It contributes to the health and welfare of Dutch citizens by enabling availability and access to innovative medicines. The products represent an important investment in public health, enabling patients to live healthier and longer. As an industry, the pharmaceutical companies make a substantial contribution to employment, education and research in Dutch society.

For more information on the activities of the Pharmaceutical Committee, please visit the Committee's website. 

Current Committee Members:

  • Roland Zegger (Chairman)
    General Manager
    Abbott B.V.  

 

  • Bart van der Lelie
    Corporate Affairs Manager
    Schering-Plough B.V.

 

  • Cees van Schagen
    Corporate Affairs Director
    GlaxoSmithKline B.V.

 

  • Marcel M. Joachimstahl
    Vice President / General Manager
    GlaxoSmithKline B.V.

 

  • P. Korte
    General Manager
    Janssen-Cilag B.V.

 

  • Rob van Aperen
    General Manager
    Pfizer B.V.

 

  • S.D.Robert Berkelbach van der Sprenkel
    Director External Affairs
    Merck Sharp & Dohme B.V.

 

 

Affiliated companies are:

 

 

 

  • Eli Lilly Nederland BV                                                     
    www.lilly.nl

 

  • GlaxoSmithKline B.V.                             
    www.gsk.nl

 

  • Janssen-Cilag B.V.                                 
    www.janssen-cilag.nl

 

  • Merck Sharp & Dohme B.V. (MSD B.V.)      
    www.msd.nl

 

  • Pfizer B.V.                                                  
    www.pfizer.nl

 

 

  • Wyeth Pharmaceuticals  B.V.                 
    www.wyeth.nl